GB201006434D0 - Novel iminosugar combinations - Google Patents

Novel iminosugar combinations

Info

Publication number
GB201006434D0
GB201006434D0 GBGB1006434.3A GB201006434A GB201006434D0 GB 201006434 D0 GB201006434 D0 GB 201006434D0 GB 201006434 A GB201006434 A GB 201006434A GB 201006434 D0 GB201006434 D0 GB 201006434D0
Authority
GB
United Kingdom
Prior art keywords
combinations
iminosugar
novel
novel iminosugar
iminosugar combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1006434.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GBGB1006434.3A priority Critical patent/GB201006434D0/en
Publication of GB201006434D0 publication Critical patent/GB201006434D0/en
Priority to PCT/GB2011/000594 priority patent/WO2011131926A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
GBGB1006434.3A 2010-04-19 2010-04-19 Novel iminosugar combinations Ceased GB201006434D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1006434.3A GB201006434D0 (en) 2010-04-19 2010-04-19 Novel iminosugar combinations
PCT/GB2011/000594 WO2011131926A1 (en) 2010-04-19 2011-04-19 Novel iminosugar combinations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1006434.3A GB201006434D0 (en) 2010-04-19 2010-04-19 Novel iminosugar combinations

Publications (1)

Publication Number Publication Date
GB201006434D0 true GB201006434D0 (en) 2010-06-02

Family

ID=42245370

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1006434.3A Ceased GB201006434D0 (en) 2010-04-19 2010-04-19 Novel iminosugar combinations

Country Status (2)

Country Link
GB (1) GB201006434D0 (en)
WO (1) WO2011131926A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2897432A1 (en) * 2013-01-09 2014-07-17 Amicus Therapeutics, Inc. Stable parenteral dnj compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2302697T3 (en) 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford LONG CHAIN N-ALQUILIC COMPOUNDS AND OXA DERIVATIVES OF THE SAME AND USE AS ANTIVIRAL COMPOSITIONS.
FR2861991B1 (en) 2003-11-07 2008-01-18 Centre Nat Rech Scient USE OF GLUCOSIDASE INHIBITORS FOR MUCOVISCIDOSE THERAPY
AU2007241622A1 (en) 2006-04-24 2007-11-01 Academisch Medisch Centrum Improved treatment of cystic fibrosis

Also Published As

Publication number Publication date
WO2011131926A1 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
HRP20181800T1 (en) Well
DK3342786T3 (en) Anti-dll3-antistof
AP3107A (en) 5-Alkynyl-pyrimidines
EP2566479A4 (en) Azaindazoles
EP2640189A4 (en) 3-deutero-pomalidomide
AP2012006640A0 (en) New aminopyrazoloquinazolines
GB201012176D0 (en) Well
DK3466977T3 (en) Anti-vla-4-antistoffer
EP2651505A4 (en) Electroporation-induced electrosensitization
EP2641891A4 (en) Pkc- activator
GB201013207D0 (en) Novel combination
IL225312A0 (en) Novel combinations
GB201000196D0 (en) Novel combination
GB201001385D0 (en) Cable-tidies
GB201006434D0 (en) Novel iminosugar combinations
AU4536P (en) TB01 Tibouchina urvilleana
AU4937P (en) FlatinsulGL Myoporum insulare
AU4931P (en) FlatwaxDarkGL Chamelaucium uncinatum
AU4822P (en) FlatwaxwhiteGL Chamelaucium uncinatum
AU4932P (en) FlatwaxpinkGL Chamelaucium uncinatum
GB201006431D0 (en) Novel iminosugar therapeutics
GB201001809D0 (en) Novel iminosugar therapeutics
GB201019442D0 (en) Novel combinations
GB201013212D0 (en) Novel combination
GB201013214D0 (en) Novel combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)